ATE441406T1 - Verbesserung der bildqualität im auge - Google Patents

Verbesserung der bildqualität im auge

Info

Publication number: ATE441406T1
Authority: AT; Austria
Prior art keywords: image quality; mind; improved image; zeaxanthin; mixtures
Prior art date: 2004-06-29

Application number

AT05759460T

Other languages

English (en)

Inventor

John Barbur

Original Assignee

Dsm Ip Assets Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-29

Filing date

2005-06-08

Publication date

2009-09-15

2005-06-08 Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv

2009-09-15 Application granted granted Critical

2009-09-15 Publication of ATE441406T1 publication Critical patent/ATE441406T1/de

Links

KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 4
JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 abstract 2
JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 abstract 2
QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 abstract 2
JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 abstract 2
239000001656 lutein Substances 0.000 abstract 2
235000012680 lutein Nutrition 0.000 abstract 2
KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract 2
229960005375 lutein Drugs 0.000 abstract 2
ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 2
235000010930 zeaxanthin Nutrition 0.000 abstract 2
239000001775 zeaxanthin Substances 0.000 abstract 2
229940043269 zeaxanthin Drugs 0.000 abstract 2
230000004075 alteration Effects 0.000 abstract 1
235000015872 dietary supplement Nutrition 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Eye Examination Apparatus (AREA)
Ultra Sonic Daignosis Equipment (AREA)

AT05759460T 2004-06-29 2005-06-08 Verbesserung der bildqualität im auge ATE441406T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04015189		2004-06-29
PCT/EP2005/006168 WO2006002735A1 (en)	2004-06-29	2005-06-08	Improvement of image quality in the eye

Publications (1)

Publication Number	Publication Date
ATE441406T1 true ATE441406T1 (de)	2009-09-15

Family

ID=35782481

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05759460T ATE441406T1 (de)	2004-06-29	2005-06-08	Verbesserung der bildqualität im auge

Country Status (9)

Country	Link
US (2)	US20080045605A1 (de)
EP (1)	EP1761254B1 (de)
JP (1)	JP5074184B2 (de)
KR (1)	KR20070027649A (de)
CN (1)	CN101094666B (de)
AT (1)	ATE441406T1 (de)
DE (1)	DE602005016405D1 (de)
ES (1)	ES2331083T3 (de)
WO (1)	WO2006002735A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080167384A1 (en) *	2005-02-11	2008-07-10	Wolfgang Schalch	Use of Zeaxanthin For the Treatment of Diseases of the Peripheral Retina
AT503329A1 (de)	2006-03-02	2007-09-15	Omnica Gmbh	Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6218436B1 (en) *	1993-06-28	2001-04-17	The Howard Foundation	Pharmaceutically active carotenoids
US5382714A (en) *	1994-03-17	1995-01-17	The Catholic University Of America	Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
US5827652A (en) *	1995-10-31	1998-10-27	Applied Food Biotechnology, Inc.	Zeaxanthin formulations for human ingestion
FR2749758B1 (fr) *	1996-06-12	1998-08-07	Oenobiol Sa Lab	Composition a activite bronzante et photoprotectrice et ses applications esthetiques
WO1997048388A1 (en) *	1996-06-17	1997-12-24	The Board Of Trustees Of The University Of Illinois	Method of retarding and ameliorating central nervous system and eye damage
US6075058A (en) *	1998-12-12	2000-06-13	Tufts University	Compositions for increased bioavailability of carotenoids
US6712466B2 (en) *	2001-10-25	2004-03-30	Ophthonix, Inc.	Eyeglass manufacturing method using variable index layer
DE60318390T2 (de) *	2002-01-30	2008-12-18	Dsm Ip Assets B.V.	Lutein/zeaxanthin gegen blendung
CN1481804A (zh) *	2002-12-17	2004-03-17	无锡杰西医药科技有限公司	防治白内障、黄斑变性等眼病的配方及其使用方法

2005
- 2005-06-08 DE DE602005016405T patent/DE602005016405D1/de not_active Expired - Lifetime
- 2005-06-08 US US11/629,997 patent/US20080045605A1/en not_active Abandoned
- 2005-06-08 CN CN2005800202695A patent/CN101094666B/zh not_active Expired - Fee Related
- 2005-06-08 ES ES05759460T patent/ES2331083T3/es not_active Expired - Lifetime
- 2005-06-08 JP JP2007519638A patent/JP5074184B2/ja not_active Expired - Fee Related
- 2005-06-08 AT AT05759460T patent/ATE441406T1/de not_active IP Right Cessation
- 2005-06-08 EP EP05759460A patent/EP1761254B1/de not_active Expired - Lifetime
- 2005-06-08 KR KR1020067027745A patent/KR20070027649A/ko not_active Ceased
- 2005-06-08 WO PCT/EP2005/006168 patent/WO2006002735A1/en not_active Ceased
2011
- 2011-03-23 US US13/064,404 patent/US20110172313A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2008505137A (ja)	2008-02-21
KR20070027649A (ko)	2007-03-09
WO2006002735A1 (en)	2006-01-12
US20080045605A1 (en)	2008-02-21
EP1761254A1 (de)	2007-03-14
JP5074184B2 (ja)	2012-11-14
ES2331083T3 (es)	2009-12-21
DE602005016405D1 (de)	2009-10-15
CN101094666A (zh)	2007-12-26
EP1761254B1 (de)	2009-09-02
CN101094666B (zh)	2010-09-29
US20110172313A1 (en)	2011-07-14

Similar Documents

Publication	Publication Date	Title
Pinto et al.	2013	N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice
IL172613A0 (en)	2006-04-10	Pan-kir2dl nk-receptor antibodies and their use in diagnostic and therapy
EP4371615A3 (de)	2024-06-26	Behandlung von amd mit aav sflt-1
WO2012038512A3 (en)	2012-05-18	Composition comprising sod, lutein and zeaxanthin
MX365525B (es)	2019-06-06	Compuestos que regulan la expresión de subunidades alfa de canales de sodio regulados por voltaje en enfermedades relacionadas con epilepsia mioclónica severa de la infancia.
WO2012125830A3 (en)	2012-11-15	Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
EA201001283A1 (ru)	2011-08-30	Комбинация витамина d и 25-гидроксивитамина d3
NO20075540L (no)	2007-11-01	Lignian-inneholdende sammensetninger
MY208400A (en)	2025-05-07	Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (ror) and pharmaceutical uses thereof
WO2018169282A3 (ko)	2019-01-10	Atpif1을 함유하는 당뇨 치료용 약학조성물
DK2111125T3 (da)	2011-06-20	Flydende formuleringer indeholdende carotinoider
EA201201239A1 (ru)	2013-02-28	Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
PH12019500949A1 (en)	2019-08-05	Ror-gamma modulators
MX2007001943A (es)	2007-05-09	Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
ATE410424T1 (de)	2008-10-15	Spirocyclische cyclohexan-derivate
MX2019003725A (es)	2019-08-12	Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma.
Musa et al.	2023	Nutritional factors: benefits in glaucoma and ophthalmologic pathologies
WO2018005801A3 (en)	2018-02-01	Novel non-systemic tgr5 agonists
CL2012002942A1 (es)	2013-04-12	Uso de un derivado sintetico de retinol e hidroxianisol butilado disuelto en aceite de soya para preparar un medicamento util en el tratamiento de un sujeto humano que sufre de la perdida o el deterioro de la vison causado por un trastorno por deficencia de retinol 11-cis producido endogenamente; composicion farmeceutica.
AR079696A1 (es)	2012-02-15	Composiciones farmacéuticas que comprenden bimatoprost, brimonidina y timolol y su uso para preparar un medicamento util para reducir la presion intraocular
WO2020142607A3 (en)	2020-08-20	Uv screening and antioxidant composition and use thereof
ATE441406T1 (de)	2009-09-15	Verbesserung der bildqualität im auge
Ahn et al.	2016	Tat-ATOX1 inhibits streptozotocin-induced cell death in pancreatic RINm5F cells and attenuates diabetes in a mouse model
MXPA05006081A (es)	2005-12-14	Nuevos compuestos moduladores de los receptores de tipo receptor activado proliferador de peroxisoma del subtipo (ppar gamma) y su uso en composiciones cosmeticas o farmaceuticas.
PH12022550938A1 (en)	2024-02-19	Products and methods using sonication to increase bioactivity of soy peptides

Legal Events

Date	Code	Title	Description
2010-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties